News

PET offers more precise screening method to select candidates for radionuclide therapy

By EurekAlert.org on October 08, 2019
A new study published in The Journal of Nuclear Medicine evaluated the role of 68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in selecting neuroendocrine tumor patients who may benefit from peptide receptor radionuclide therapy (PRRT).

2019 Neuroendocrine Tumor Patient Conference

July 26, 2019
Presented by the UCSF Helen Diller Family Comprehensive Cancer Center and NorCal CarciNET Community, in collaboration with Stanford University and with generous support provided by supporters and industry partners. Co-Host: NorCal CarciNET Community  Sunday, February 10, 2019 at 8:30am to 5:00am...

NETRF Announces $2.5 Million in Research to Advance the Treatment of Neuroendocrine Tumors

By Donna Dubuc, Director of Communications, NETRF on February 05, 2019
(Boston, MA) — The Neuroendocrine Tumor Research Foundation (NETRF) continues its aggressive funding of neuroendocrine cancer research with eight new grants totaling $2.5 million. With this newest round of funding, NETRF expands its portfolio to include research into lung neuroendocrine tumors (...

UCSF Faculty Named to NANETs Leadership Roles

September 27, 2018
The North American Neuroendocrine Tumor Society (NANETS) recently appointed two UCSF faculty members to leadership roles for 2018-2020. Emily Bergsland, MD, will serve as Vice-Chair, and Eric Nakakura, MD, PhD, will serve as a member of the NANETs Board of Directors. The North American...

Fall/Winter 2017: UCSF Oncology Connection

By UCSF Health on November 15, 2017
Fall/Winter 2017: UCSF Oncology ConnectionINSIDE THIS ISSUE A Central Home for Patients with Neuroendocrine Tumors.

Emily Bergsland receives Ernest H. Rosenbaum, MD Committment to Patient Care Award

June 01, 2017
Emily Bergsland, MD received the Ernest H. Rosenbaum, MD Commitment to Patient Care Award for her long-standing dedication to her patients and her ongoing efforts to improve the care of people with neuroendocrine tumors. The Ernest H. Rosenbaum, MD, Commitment to Patient Care Award recognizes...

Eric Nakakura, MD receives NETRF Award

May 23, 2017
NETRF Award awarded to Eric Nakakura, MD, PhD for his projected entitled “ Development of a Mouse Model of Pancreatic Neuroendocrine Cancer” The objective his research is to characterize a xenograft mouse model of pancreatic neuroendocrine cancer. This model will be useful to help develop and test...

International Research Team Awarded $1.2m Grant to Study Small Intestinal Neuroendocrine Tumors

By Richard Barg on May 04, 2017
Eric Nakakura, M.D., Ph.D., Associate Professor of Surgery at UCSF and a leading authority on neuroendocrine tumors of the gastrointestinal (GI) tract and pancreas, is among a group of researchers awarded a $1.2m accelerator grant to elucidate the causes of small intestinal ne

Michael German, MD named NETRF Petersen Investigator

December 21, 2016
NETRF named Michael German, MD as the NETRF Petersen Investigator for his project entitled, “Treating Neuroendocrine Tumors via Synthetic Lethality” The objective his research is to analyze how the UPR-MEN1-MAPK pathways interact to control neuroendocrine cell survival and death, and to evaluate...

Thomas Hope receives NETRF/ERF Nuclear Medicine Pilot Research Grant

December 01, 2016
The first NETRF/ERF Nuclear Medicine Pilot Research Grant has been awarded to Thomas Hope, MD. NETRF is funding the grant to explore innovations in nuclear medicine focused on diagnosis and treatment. ERF—The Education and Research Foundation for Nuclear Medicine and Molecular Imaging—solicited...